Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory

[1]  D. Selley,et al.  ΔFosB induction correlates inversely with CB1 receptor desensitization in a brain region-dependent manner following repeated Δ9-THC administration , 2014, Neuropharmacology.

[2]  Adam W. Bero,et al.  Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories , 2014, Cell.

[3]  T. Krahe,et al.  Synaptic Dysfunction in the Hippocampus Accompanies Learning and Memory Deficits in Human Immunodeficiency Virus Type-1 Tat Transgenic Mice , 2013, Biological Psychiatry.

[4]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.

[5]  J. Sweatt,et al.  Epigenetic Mechanisms in Learned Fear: Implications for PTSD , 2013, Neuropsychopharmacology.

[6]  T. Abel,et al.  NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. , 2012, The Journal of clinical investigation.

[7]  Jyothi Arikkath,et al.  Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex , 2012, Nature Protocols.

[8]  K. Vogt,et al.  Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome , 2012, Proceedings of the National Academy of Sciences.

[9]  S. Yamawaki,et al.  Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene. , 2012, Journal of psychiatric research.

[10]  J. Cyster,et al.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.

[11]  N. Tronson,et al.  Fear conditioning and extinction: emotional states encoded by distinct signaling pathways , 2012, Trends in Neurosciences.

[12]  Michael A. Langston,et al.  GeneWeaver: a web-based system for integrative functional genomics , 2011, Nucleic Acids Res..

[13]  H. Bading,et al.  Nuclear Calcium-VEGFD Signaling Controls Maintenance of Dendrite Arborization Necessary for Memory Formation , 2011, Neuron.

[14]  J. David Sweatt,et al.  Epigenetic Mechanisms in Cognition , 2011, Neuron.

[15]  Stephen Maren,et al.  Seeking a Spotless Mind: Extinction, Deconsolidation, and Erasure of Fear Memory , 2011, Neuron.

[16]  E. Briard,et al.  BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution , 2011, ChemMedChem.

[17]  Volker Brinkmann,et al.  Sphingosine 1-phosphate (S1P) , 2011, Neurology.

[18]  Inbal Goshen,et al.  Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.

[19]  Marcelo A. Wood,et al.  HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation , 2010, The Journal of Neuroscience.

[20]  D. Herr,et al.  FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation , 2010, Proceedings of the National Academy of Sciences.

[21]  L. Tsai,et al.  Targeting the correct HDAC(s) to treat cognitive disorders. , 2010, Trends in pharmacological sciences.

[22]  Volker Brinkmann,et al.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.

[23]  M. Rossner,et al.  Cognitive and Sensorimotor Gating Impairments in Transgenic Mice Overexpressing the Schizophrenia Susceptibility Gene Tcf4 in the Brain , 2010, Biological Psychiatry.

[24]  J. Peters,et al.  Induction of Fear Extinction with Hippocampal-Infralimbic BDNF , 2010, Science.

[25]  M. Moser.  Faculty Opinions recommendation of Regulation of learning and memory by meningeal immunity: a key role for IL-4. , 2010 .

[26]  M. Navre,et al.  Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. , 2010, Bioorganic & medicinal chemistry letters.

[27]  Cheng Luo,et al.  SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.

[28]  J. Kipnis,et al.  Regulation of learning and memory by meningeal immunity: a key role for IL-4 , 2010, The Journal of experimental medicine.

[29]  Lennart Opitz,et al.  Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.

[30]  C. Wotjak,et al.  Dissociation of within- and between-Session Extinction of Conditioned Fear , 2010, The Journal of Neuroscience.

[31]  Ludwig Kappos,et al.  A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[32]  G. Glover,et al.  A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human , 2010, Science.

[33]  G. Francis,et al.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.

[34]  Cheng Luo,et al.  Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.

[35]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[36]  M. Wood,et al.  Modulation of long-term memory for object recognition via HDAC inhibition , 2009, Proceedings of the National Academy of Sciences.

[37]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[38]  S. Haggarty,et al.  HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.

[39]  Alcino J. Silva,et al.  The molecular and cellular biology of enhanced cognition , 2009, Nature Reviews Neuroscience.

[40]  L. Thompson,et al.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.

[41]  J. Kipnis,et al.  Adaptive immunity affects learning behavior in mice , 2008, Brain, Behavior, and Immunity.

[42]  T. Bredy,et al.  The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. , 2008, Learning & memory.

[43]  E. Persohn,et al.  Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis , 2007, Journal of Pharmacology and Experimental Therapeutics.

[44]  J. Liao,et al.  Distribution of sphingosine kinase activity and mRNA in rodent brain , 2007, Journal of neurochemistry.

[45]  K. Lattal,et al.  Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. , 2007, Behavioral neuroscience.

[46]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[47]  T. Bredy,et al.  Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. , 2007, Learning & memory.

[48]  Robert W. Williams,et al.  Ethanol-Responsive Brain Region Expression Networks: Implications for Behavioral Responses to Acute Ethanol in DBA/2J versus C57BL/6J Mice , 2005, The Journal of Neuroscience.

[49]  R. Proia,et al.  Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720* , 2004, Journal of Biological Chemistry.

[50]  D. Molfese,et al.  Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.

[51]  E. Kandel,et al.  Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.

[52]  Yaniv Ziv,et al.  T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Okada,et al.  Sphingosine Kinase 2 Is a Nuclear Protein and Inhibits DNA Synthesis* , 2003, Journal of Biological Chemistry.

[54]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[55]  M. Miles,et al.  A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. , 2002, Journal of molecular biology.

[56]  E. Kandel,et al.  Some Forms of cAMP-Mediated Long-Lasting Potentiation Are Associated with Release of BDNF and Nuclear Translocation of Phospho-MAP Kinase , 2001, Neuron.

[57]  A. Lichtman,et al.  Differential effects of delta 9-THC on spatial reference and working memory in mice. , 2001, Psychopharmacology.

[58]  S. Milstien,et al.  Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.

[59]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[60]  S. Oliviero,et al.  Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Oliviero,et al.  血小板由来増殖因子/血管内皮増殖因子ファミリーと相関するc‐fos誘導性遺伝子の同定 , 1996 .